These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 30615336
1. [The methods of detection of binding and neutralizing antibodies to preparations of interferon-beta]. Nazarov VD, Lapin SV, Surkova EA, Makshakov GS, Mazing AV, Evdoshenko EP, Totolian AA. Klin Lab Diagn; 2016 Oct; 61(10):710-4. PubMed ID: 30615336 [Abstract] [Full Text] [Related]
4. [Significance of neutralizing antibodies to immunomodulatory therapy and their laboratory analysis in multiple sclerosis]. Seres E, Vécsei L. Ideggyogy Sz; 2006 May 20; 59(5-6):156-62. PubMed ID: 16786710 [Abstract] [Full Text] [Related]
6. Neutralizing and binding antibodies to interferon beta in patients with multiple sclerosis: a comparison of assay results from three italian centres. Bellomi F, Bramanti P, Trojano M, Scagnolari C, Muto A, Sessa E, La Volpe V, Russo P, Antonelli G. J Immunoassay Immunochem; 2009 May 20; 30(1):40-50. PubMed ID: 19117201 [Abstract] [Full Text] [Related]
7. Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study. Jensen PEH, Warnke C, Ingenhoven K, Piccoli L, Gasis M, Hermanrud C, Fernandez-Rodriguez BM, Ryner M, Kramer D, Link J, Ramanujam R, Auer M, Buck D, Grummel V, Bertotti E, Fissolo N, Oliver-Martos B, Nytrova P, Khalil M, Guger M, Rathmaier S, Sievers-Stober C, Lindberg RLP, Hässler S, Bachelet D, Aktas O, Donnellan N, Lawton A, Hemmer B, Havrdova EK, Kieseier B, Hartung HP, Comabella M, Montalban X, Derfuss T, Sellebjerg F, Dönnes P, Pallardy M, Spindeldreher S, Broët P, Deisenhammer F, Fogdell-Hahn A, Sorensen PS, ABIRISK Consortium. J Neuroimmunol; 2019 Jan 15; 326():19-27. PubMed ID: 30447419 [Abstract] [Full Text] [Related]
8. Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta. Sominanda A, Lundkvist M, Fogdell-Hahn A, Hemmer B, Hartung HP, Hillert J, Menge T, Kieseier BC. Arch Neurol; 2010 Sep 15; 67(9):1095-101. PubMed ID: 20837854 [Abstract] [Full Text] [Related]
9. Antibodies to interferon beta in patients with multiple sclerosis receiving CinnoVex, rebif, and betaferon. Zare N, Zarkesh-Esfahani SH, Gharagozloo M, Shaygannejad V. J Korean Med Sci; 2013 Dec 15; 28(12):1801-6. PubMed ID: 24339712 [Abstract] [Full Text] [Related]
13. Persistency of neutralizing antibodies depends on titer and interferon-beta preparation. Hegen H, Schleiser M, Gneiss C, Di Pauli F, Ehling R, Kuenz B, Lutterotti A, Berger T, Deisenhammer F. Mult Scler; 2012 May 15; 18(5):610-5. PubMed ID: 22013146 [Abstract] [Full Text] [Related]